Anticancer Drug Development Guide - Preclinical Screening, Clinical Trials, and Approval (Paperback, Softcover reprint of the original 1st ed. 1997)

Experienced cancer researchers from pharmaceutical companies, government laboratories, and academia comprehensively review and describe the arduous process of cancer drug discovery and approval. They focus on using preclinical in vivo and in vitro methods to identify molecules of interest, detailing the targets and criteria for success in each type of testing and defining the value of the information obtained from the various tests. They also define each stage of clinical testing, explain the criteria for success, and outline the requirements for FDA approval. A companion volume by the same editor (Cancer Therapeutics: Experimental and Clinical Agents) reviews existing anticancer drugs and potential anticancer therapies. These two volumes in the Cancer Drug Discovery and Development series reveal how and why molecules become anticancer drugs and thus offer a blueprint for the present and the future of the field.

General

Imprint:	Springer-Verlag New York
Country of origin:	United States
Series:	Cancer Drug Discovery and Development
Release date:	June 2013
First published:	1997
Editors:	Beverly A. Teicher
Dimensions:	254 x 178 x 18mm (L x W x T)
Format:	Paperback
Pages:	311
Edition:	Softcover reprint of the original 1st ed. 1997
ISBN-13:	978-1-4615-8154-3
Categories:	Books > Medicine > Other branches of medicine > Pharmacology > General Books > Medicine > Clinical & internal medicine > Diseases & disorders > Oncology > General
LSN:	1-4615-8154-0
Barcode:	9781461581543

Is the information for this product incomplete, wrong or inappropriate? Let us know about it.

Does this product have an incorrect or missing image? Send us a new image.

Is this product missing categories? Add more categories.

Review This Product

No reviews yet - be the first to create one!